Abstract-The developmental pattern of L-['HIglutamate binding to rat brain in the presence of saturating concentrations of unlabeled N-methyl-o-aspartate (NMDA), kainate (KA) and quisqualate (QQA) was examined in an autoradiographic assay. The unique glutamate binding site defined by this assay displayed four distinct, reSionaliy specific patterns of deve~~ent.
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( The effects of excitatory amino acids are mediated by a variety of different receptor types, At least five distinct receptors have been identified and paltry chara~te~ed. There are receptors named for kainate @A), quisqualate (QQA) and N-methyl-D-aspa~~te (NMDA), each of which appears to be associated with an ion channel. 'vz4 There is also a metabo~opic receptor which is linked to phosphoinositot metabolism. 16,21 Finally eie~trophysioio~~~ studies have demonstrated a receptor at which 2"amin~~-phosphonob~~yrate (APB) is an anta~onist.4
There may also be other excitatory amino acid receptor types which have not yet been characterized. For example, glutamate still has excitatory e~e~trophysiolo~ca~ actions in the presence of antagonists in concentrations sufficient to block both NMDA and K~QQA responses."' Little is known about the developmental profile or function of these NMDA-, KA-, QQA-insensitive excitatory glutamate receptors.
We have recently characterized a unique neuronal glutamate recognition site in rat brain that is distinct from any known receptor type.9 This site was assayed in the presence of saturating con~entrations of NMDA, QQA and KA, and binding was dependent upon chloride ions and enhanced by calcium ions. This site may correspond to the calcium-and chlo~de-de~ndent site first described by ~onagha~ et al. i3
This unique non-NMDA, nor&A, non-QQA (NNKQ) site is expressed transiently in the giobus pallidus during development of human and rat brain.? Although assay conditions were different in the original report describing this transient glutamatergic innervation of globus pai~idus, reanalysis of our binding data and subsequent expe~ments have ~nfirmed that the NNKQ comprised more than 50% of the binding we measured. In the globus pallidus, expression of this site correlated well with other biochemical measures of glutamatergi~ inne~ation during development .7 *Address ~~es~~dence to: J. T. Gr~namyre, repayment of Neurology, Unive~ity of Rochester Medical Center, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, U.S.A. Abbrcvti0rr.r: APB, 2-~ino4phosphonbutyrate; Cb-G, cerebellar grannle cell layer; Cb-M, cerebehar molecular layer; CC, central gray; DG, dentate gyms; DLG, dorsal lateral gen~c~late; Ent, entorhin~ cortex; Fr, frontal cortex, IQ, inferior cohiculus; KA, kainate; MG, medial genicuhte; NMDA, N-methyl-castrate; NNKQ, non-NhlDA, non-K& non-QQA ghtamate binding site; PNR, postnatal day; QQA, quisqualate; Rt, reticular nucleus of thalamus; SITS, ~a~tam~do~'-jsotbi~yanostilbe~e-2,~-disulfo~ic acid; SLM, stratum lacu~osum moiecula~; Str, strati; VPM, ventral posterior media1 nucleus of thalamus.
